🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

5,609 results for “AB” Clear

  1. metformin

    Boehringer Ingelheim

    Diabetes Mellitus, Type 2

    approved small molecule completed

    1 trial

  2. methotrexate (MTX)

    AbbVie

    Psoriatic Arthritis

    approved small molecule completed

    1 trial

  3. mirabegron

    Hospital Authority, Hong Kong

    Sjogren's Syndrome

    approved small molecule active

    1 trial

  4. mirabegron

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Sjogren's Syndrome

    approved small molecule active

    1 trial

  5. moxifloxacin

    Hospital Authority, Hong Kong

    Intra-abdominal Infection

    approved small molecule completed

    1 trial

  6. mycophenolate mofetil (Myfenax)

    Teva Pharma GmbH

    Stable Renal Transplant Recipients

    approved small molecule terminated

    1 trial

  7. naltrexone for extended release injectable suspension

    BRIGHT MINDS BIOSCIENCES INC.

    Substance-Related Disorders

    approved small molecule completed

    1 trial

  8. neoadjuvant therapy

    The First People's Hospital of Lianyungang

    Hepatocellular Carcinoma Resectable

    approved other active

    1 trial

  9. pioglitazone

    GlaxoSmithKline

    Diabetes Mellitus, Type 2

    approved small molecule terminated

    1 trial

  10. pioglitazone

    Takeda

    Type 2 Diabetes

    approved small molecule completed

    1 trial

  11. pioglitazone

    Takeda

    Type 2 Diabetes Mellitus

    approved small molecule completed

    4 trials

  12. pregabalin

    Pfizer

    Diabetic Neuropathy, Painful

    approved small molecule completed

    1 trial

  13. pregabalin and celecoxib

    Pfizer

    Chronic Low Back Pain With a Neuropathic Component

    approved small molecule terminated

    1 trial

  14. premeal insulin lispro mixtures

    Eli Lilly and Company

    Diabetes Mellitus, Type 2

    approved small molecule completed

    1 trial

  15. prescribing anapproved drug, examination

    The First People's Hospital of Lianyungang

    Irritable Bowel Syndrome With Diarrhea

    approved small molecule active

    1 trial

  16. quetiapine fumarate tablet (Seroquel)

    The First People's Hospital of Lianyungang

    Bipolar Disorder

    approved small molecule active

    1 trial

  17. rituximab combined with corticosteroids

    The First People's Hospital of Lianyungang

    Primary Membranous Nephropathy

    approved small molecule active

    1 trial

  18. tong-jiang granules

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Non-erosive Reflux Disease/Diarrheal Irritable Bowel Syndrome

    approved small molecule active

    1 trial

  19. trastuzumab [Herceptin]

    Hoffmann-La Roche

    Gastric Cancer

    approved small molecule terminated

    1 trial

  20. vaccinated with Sabin IPV

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Polio

    approved mab completed

    1 trial

  21. 25% Carbohydrate solution (CHO drinking)

    Hospital Authority, Hong Kong

    Type2diabetes

    other completed

    1 trial

  22. 5-gene classification model

    Hospital Authority, Hong Kong

    ABO Blood Type Incompatible Kidney Transplantation

    other completed

    1 trial

  23. 89Zr-trastuzumab

    United Therapeutics Europe Ltd

    Breast Cancer Metastases

    other completed

    1 trial

  24. Abbreviated non-contrast MRI of the liver

    Hospital Authority, Hong Kong

    Hepatocellular Carcinoma

    other active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources